Author: Ritika Pandey, Research Analyst
17 April 2025
Increased demand for Personalized Medicine: The need for precise molecular profiling is accentuating the market growth.
Technological Advancements: Several technological innovations such as spatial barcoding, and AI integration augment data analysis and accessibility.
Applications in Research: Increasing use in neuroscience, oncology, and developmental biology are expanding the Spatial Genomics & Transcriptomics market.
Funding & Investments: Significant investments from the government and private organizations in research and development are enabling the development of advanced tools and technologies.
According to a new report by UnivDatos, the Spatial Genomics & Transcriptomics Market is expected to reach USD Billion in 2032 by growing at a CAGR of 12.03% during the forecast period (2024-2032). With the increasing pervasiveness of chronic diseases, there is a demand for new cost-effective, and efficient health management solutions, such as Spatial Genomics & Transcriptomics. With advancements in technology and integration with AI and Bioinformatics, it fulfills the demand for personalized medicine. Moreover, partnerships and collaborations with governments, institutions, and pharmaceutical providers are becoming increasingly common. Through partnerships with drug discoverers, Spatial Genomics & Transcriptomics suppliers can provide various products focused on cellular and tissue analysis. For instance, on January 5, 2022, Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Akoya Biosciences Inc., announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples. Through this agreement, the partners would bring to the market an automated, spatial multiomics workflow that can perform rapid, in situ analysis of multiple analytes, at single cell resolution, across whole slides.
Here are a few examples of government regulations, laws, and legal frameworks that influence the Spatial Genomics & Transcriptomics market:
Federal Food, Drug, and Cosmetic Act (FD&C Act): The FD&C Act of the United States oversees and regulates the production, sale, and distribution of food, drugs medical devices, and cosmetics. It intends to protect the general public from adulterated and misbranded products manufactured and sold in the United States.
Drug Enforcement Administration (DEA): The Drug Enforcement Administration (DEA) enforces the controlled substance laws and regulations of the United States. It manages the drug intelligence program in cooperation with federal, state, local, and foreign officials to collect, analyze, and disseminate strategic and operational drug intelligence information.
Data Integrity: Regulations such as 21 CFR Part 11 enforces secure electronic record-keeping and signatures to maintain data integrity.
International Council for Harmonisation (ICH): The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and ICH guidelines.
According to the report, the impact of Spatial Genomics & Transcriptomics resources has been identified to be high for the Asia-Pacific area. Some of how this impact has been felt include:
Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032). The increasing rampancy of chronic and infectious diseases, R&D investments, and the rise in the number of research laboratories in Asia-Pacific is fuelling this market. Rapid economic growth, and improvements, in the healthcare infrastructure in the Asia Pacific countries are enabling the adoption of advanced genomic tools. Further, the partnership between international corporations and regional research institutes will help to boost regional revenue creation. Apart from this, the introduction of innovative and cost-effective sequencing platforms for academic and translational research is further driving the market. According to the Indian Council of Medical Research (ICMR) 2023, India had 163 Viral Research Diagnostic Laboratories, 117 Multidisciplinary Research Units (MRUs) and 35 Model Rural Health Research Units (MRHRUs). For instance, on October 27, 2022, Vizgen, announced the availability of its MERSCOPE® spatial genomics platform in Asia-Pacific (APAC), Europe, the Middle East, and Africa (EMEA). To support its global expansion, Vizgen has signed agreements with the distributors of the APAC region with Gene Company covering China/Hong Kong and PRIMETECH covering Japan.
Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/spatial-genomics-and-transcriptomics-market?popup=report-enquiry
Market Size, Trends, & Forecast by Revenue | 2024−2032.
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis By Technology Type, By Product Type, By End-Users, and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Get a call back
